← All stocks

SERA PROGNOSTICS, INC.

SERA Net selling
CIK 0001534969 #4456 in the set updated 17 Sep 2026
Bought (120 mo)
$9.60K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.26M
$823.53K on a plan · $839.99K straight out of an exercise
Sold at will
$4.60M
160 of 213 sales
Net
−$6.25M
−$4.59M against sales at will

By person

23 insiders · 219 transactions
2.7×

Zhenya Lindgardt holds only 2.7 times base salary in stock. $1.68M of shares against $607.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Zhenya Lindgardt last reported holding, valued at $2.00, the price Class A Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lindgardt Zhenya
Chief Executive Officer
$2.12M (25)
−$2.12M
837,848
1.7%
$1.68M
Boniface John J.
Chief Scientific Officer
$1.57M (46)
−$1.57M
145,842
0.289%
$291.68K
+1,148%
Aerts Austin
Chief Financial Officer
$642.87K (27)
−$642.87K
301,190
0.597%
$602.38K
+5,084%
Kearney Paul
Chief Data Officer
$579.32K (22)
−$579.32K
163,961
0.325%
$327.92K
Jackson Benjamin
General Counsel
$9.60K (1)
$547.46K (22)
−$537.86K
159,566
0.316%
$319.13K
+883.9%
Harrison Robert Gardner
Chief Information Officer
$515.91K (30)
−$515.91K
76,712
0.152%
$153.42K
+1,434%
Phillips Joshua
Director
$230.47K (16) scheduled
−$230.47K
2,919,205
5.8%
$5.84M
+0.6%
Lawrence Sandra AJ
Director
$23.05K (4) scheduled
−$23.05K
41,175
0.082%
$82.35K
+1,660%
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
$13.13K (2)
−$13.13K
76,198
0.151%
$152.40K
Mirza Mansoor Raza
Director
$10.05K (17)
−$10.05K
81,937
0.162%
$163.87K
Inglis Tiffany Eul Davis
Chief Medical Officer
$1.70K (2)
−$1.70K
91,589
0.181%
$183.18K
Blue Ox Healthcare Partners, LLC entity
10% owner
3,841,894
7.6%
$7.68M
+7.2%
CRITCHFIELD GREGORY C
Director
846,886
1.7%
$1.69M
+29.7%
Trimble Ryan
Director
123,267
0.244%
$246.53K
+228.3%
Gleason Scott
Chief Financial Officer
117,924
0.234%
$235.85K
Kamdar Kim P.
Director
58,420
0.116%
$116.84K
+55.6%
Barlow Jane F
Director
47,088
0.093%
$94.18K
Capone Mark Christopher
Director
44,379
0.088%
$88.76K
MOYES JAY M
Chief Financial Officer
35,630
0.071%
$71.26K
Elliott Jeffrey Thomas
Director
30,534
0.060%
$61.07K
Foley Michael R
Chief Medical Officer
27,000
0.053%
$54.00K
Altomare Nadia
Chief Commercial Officer
18,300
0.036%
$36.60K
Wilson Marcus Dean
Director
7,117
0.014%
$14.23K
Insider
Date
Role
Action
Shares
Price
Amount
Jackson Benjamin
14 Jun 2022
General Counsel
Buy
8,000
$1.20
$9.60K

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 43
Sales straight out of an exercise 10
Sales at will 160
Transactions with no price 0
Shares from compensation/vesting 13,000,720
Sales filed before the plan box existed 20
History held since 21 Jul 2021